Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer-Reference-Cited by-同舟云学术

Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer

Published:2022-09 Issue: Volume:153 Page:113440
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Urbaniak Alicja,Reed Megan R.,Heflin Billie,Gaydos John,Piña-Oviedo Sergio,Jędrzejczyk Marta,Klejborowska Greta,Stępczyńska Natalia,Chambers Timothy C.,Tackett Alan J.,Rodriguez Analiz,Huczyński Adam,Eoff Robert L.,MacNicol Angus M.

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference63 articles.

1. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015 introduction;Ostrom;Neuro-Oncology,2018

2. Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma a randomized clinical trial preliminary communication, TRIAL Regist. Clin. Identifier NCT00916409;Stupp;JAMA,2015

3. The somatic genomic landscape of glioblastoma;Brennan;Cell,2013

4. Single-cell RNA-Seq analysis of infiltrating neoplestic cells at the migrating front of human glioblastoma;Darmanis;Cell Rep.,2017

5. An integrative model of cellllular states, plasticity, and genetics for glioblastoma;Neftel;Cell,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ivermectin and its synthetic derivatives – A new class of anticancer agents;European Journal of Medicinal Chemistry Reports;2024-12

2. Subcellular Drug Distribution: Exploring Organelle-Specific Characteristics for Enhanced Therapeutic Efficacy;Pharmaceutics;2024-09-04

3. Golgi apparatus targeted therapy in cancer: Are we there yet?;Life Sciences;2024-09

4. Lithium Chloride rescues Monensin-potentiated Wnt signaling inhibition in inflammatory bone loss in rats;2024-06-28

5. T cell-mediated tumor killing based signature to predict the prognosis and immunotherapy for glioblastoma;Heliyon;2024-05